Documents

A list of downloadable documents created during development.

Urticaria (chronic spontaneous, previously treated) - omalizumab [ID707]: equality impact assessment: scoping

Urticaria (chronic spontaneous, previously treated) - omalizumab [ID707]: final scope

Urticaria (chronic spontaneous, previously treated) - omalizumab [ID707]: final matrix

Urticaria (chronic spontaneous, previously treated) - omalizumab [ID707]: draft scope for consultation (pre-referral) - November 2013

Urticaria (chronic spontaneous, previously treated) - omalizumab [ID707]: provisional matrix (pre-referral) - November 2013